Fleroxacin vs ciprofloxacin in treatment of bacterial infection
Xi Xia
Abstract
Xi Xia
Abstract
To evaluate the efficacy and safety of fleroxacin injection vs ciprofloxacin injection in treatment of acute bacterial infection. METHODS: One hundred and twenty-two patients with respiratory and urinary tract infections were randomly divided into 2 groups, 61 patients were treated with fleroxacin; 61 patients were treated with ciprofloxacin. Another 40 Patients treated with flexoxacin as open treated group. All were 0. 2-0. 4 g iv drip, qd (fleroxacin) or bid (ciprofloxacin) for 714 d. RESULTS: The overall clinical efficacy rates of fleroxacin was 93. 1 % (94/101 ). The randomized comparison showed that the clinical efficacy rates of fleroxacin and ciprofloxacin were similar 92% (56/ 61) vs 82% (50/61 ), P 0. 05, but the bacterial clearance rate for fleroxacin(94% ) was higher than that for ciprofloxacin (86%, P0. 05). The incidence of adverse reactions for fleroxacin and ciprofloxacin were 6 % and 8 %, respectively (P 0. 05). CONCLUSION: Fleroxacin injection is an effective and Safe antihacterial for treatment of bacterial infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To evaluate the efficacy and safety of fleroxacin injection vs ciprofloxacin injection in treatment of acute bacterial infection. METHODS: One hundred and twenty-two patients with respiratory and urinary tract infections were randomly divided into 2 groups, 61 patients were treated with fleroxacin; 61 patients were treated with ciprofloxacin. Another 40 Patients treated with flexoxacin as open treated group. All were 0. 2-0. 4 g iv drip, qd (fleroxacin) or bid (ciprofloxacin) for 714 d. RESULTS: The overall clinical efficacy rates of fleroxacin was 93. 1 % (94/101 ). The randomized comparison showed that the clinical efficacy rates of fleroxacin and ciprofloxacin were similar 92% (56/ 61) vs 82% (50/61 ), P 0. 05, but the bacterial clearance rate for fleroxacin(94% ) was higher than that for ciprofloxacin (86%, P0. 05). The incidence of adverse reactions for fleroxacin and ciprofloxacin were 6 % and 8 %, respectively (P 0. 05). CONCLUSION: Fleroxacin injection is an effective and Safe antihacterial for treatment of bacterial infection.
Key concepts: Fleroxacin, Ciprofloxacin, Medicine, Internal medicine, Adverse effect, Gastroenterology, Antibiotics, Microbiology